Appendix A
Agenda

FORUM ON EMERGING INFECTIONS

Board on Global Health

Institute of Medicine

The National Academies

THE IMPACT OF GLOBALIZATION ON INFECTIOUS DISEASE EMERGENCE AND CONTROL: EXPLORING THE CONSEQUENCES AND OPPORTUNITIES

April 16–17, 2002

AGENDA

Tuesday, April 16, 2002

8:30

Continental Breakfast

9:00

Welcome and Opening Remarks

Adel Mahmoud, President, Merck Vaccines Chair

Forum on Emerging Infections

Session I: The Global Movement of Populations, Products, and Pathogens

Moderator: James Hughes, Assistant Surgeon General and Director, National Center for Infectious Diseases, CDC

9:15

The World and Its Moving Parts

Martin Cetron, Deputy Director, Division of Quarantine,

National Center for Infectious Diseases, CDC



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary Appendix A Agenda FORUM ON EMERGING INFECTIONS Board on Global Health Institute of Medicine The National Academies THE IMPACT OF GLOBALIZATION ON INFECTIOUS DISEASE EMERGENCE AND CONTROL: EXPLORING THE CONSEQUENCES AND OPPORTUNITIES April 16–17, 2002 AGENDA Tuesday, April 16, 2002 8:30 Continental Breakfast 9:00 Welcome and Opening Remarks Adel Mahmoud, President, Merck Vaccines Chair Forum on Emerging Infections Session I: The Global Movement of Populations, Products, and Pathogens Moderator: James Hughes, Assistant Surgeon General and Director, National Center for Infectious Diseases, CDC 9:15 The World and Its Moving Parts Martin Cetron, Deputy Director, Division of Quarantine, National Center for Infectious Diseases, CDC

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary 9:35 Global Migration and Infectious Diseases Danielle Grondin, Director, Migration Health Services, International Organization of Migration 9:55 Globalization of the Food Supply David Acheson, Chief Medical Officer, Food Safety and Inspection Service, USDA 10:15 Changing Vector Ecologies: Political Geographic Perspectives Jonathan Mayer, Professor, Geography, College of Arts and Sciences, University of Washington, Seattle 10:35 BREAK 10:50 Invited Discussion: A Response to the Shifting Trends   Moderator: Margaret Hamburg, Vice-President, Biologicals Program, Nuclear Threat Initiative Stephen Corber, Director, Division of Disease Prevention and Control, Pan American Health Organization Mary Wilson, Professor of Medicine, Harvard Medical School, Population and International Health Judith Miller, Journalist, the New York Times David Heyman, Senior Fellow, Center for Strategic and International Studies 12:30 Lunch Session II: Addressing the Health Challenges from Globalization Moderator: Patrick Kelley, Director, DoD Global Emerging Infections Surveillance and Response Systems, Walter Reed Army Institute of Research 1:30 The Global Infectious Disease Threat David Gordon, Intelligence Officer, Economics and Global Health Issues, National Intelligence Council 1:50 Health, Human Rights, and Humanitarian Assistance: The Medical and Public Health Response to Crises and Disasters Jennifer Leaning, Professor, Population and International Health, Harvard University

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary 2:10 Social Aspects of Public Health Challenges in a Period of Globalization: The Case of Russia Andrey Demin, President, Russian Public Health Association and Professor, I.M. Sechenov Medical Academy, Moscow 2:30 Considerations for Drug Access and Delivery in the Developing World Robert Redfield, Professor and Associate Director, Institute of Human Virology, University of Maryland, Baltimore 2:50 Impediments to Global Surveillance and Open Reporting of Infectious Diseases Richard Cash, Lecturer on International Health, Harvard School of Public Health 3:10 International Law, Infectious Disease, and Globalization David Fidler, Professor of Law and Ira C. Batman Faculty Fellow, School of Law, Indiana University 3:30 BREAK 3:45 Invited Discussion: Considering the Resources and Capacity for the Response   Moderator: Stanley Lemon, Dean of Medicine, University of Texas, Medical Branch, Galveston Farley Cleghorn, Senior Scientist, Institute of Human Virology, University of Maryland, Baltimore Ann Marie Kimball, Professor, Epidemiology and Health Services, University of Washington, Seattle Michele Barry, President, American Society of Tropical Medicine and Hygiene, Professor, Yale University, School of Medicine Jonathan Patz, Associate Professor, Bloomberg School of Public Health, Johns Hopkins University 5:30 Adjournment of the first day 5:45 Reception, Members Room of the NAS 6:15 Dinner Meeting for Forum Members

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary Wednesday, April 17, 2002 8:30 Continental Breakfast 9:00 Opening Remarks/Day One Summary Stanley Lemon Vice-Chair, Forum on Emerging Infections Session III: Creating Opportunities from Globalization: A Framework for Progress Moderator: Michael Zeilinger, Public Health Advisor, Team Leader, Infectious Diseases, USAID 9:15 Globalization and Health: A Framework for Analysis and Action Douglas Klaucke, Communicable Disease Surveillance and Response, World Health Organization 9:35 New Directions in Capacity Building Pierce Gardner, Senior Advisor for Clinical Research and Training, Fogarty International Center, NIH 9:55 Partnering for Success: The Role of Private-Public Sector Collaboration Roy Widdus, Project Manager, Initiative for Public-Private Partnerships for Health, Geneva 10:15 The Current Situation and Perspectives of International Collaboration in the Field of Biomedical Sciences: The Example of the State Research Center of Virology and Biotechnology (VECTOR) Sergei Netesov, Deputy Director, VECTOR Laboratories, Koltsovo, Russia 10:35 Protecting the Nation’s Health in an Era of Globalization, CDC’s Global Infectious Disease Strategy Eric Mintz, Acting Associate Director for Global Health, CDC 10:55 The Global Fund: A Brave New World William Steiger, Special Assistant to the Secretary, International Affairs, Department of Health and Human Services

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary 11:15 BREAK 11:30 Invited Discussion: Considerations for Shaping the Agenda Moderator: Carlos Lopez, Research Fellow, Eli Lilly and Company   Olusoj Adeyi, Senior Health Specialist, World Bank William Makgoba, President, Medical Research Council of South Africa (by teleconference) Mark Miller, Associate Director for Research and Director, Division of International Epidemiology and Population Studies, Fogarty International Center, NIH Ralph Timperi, Chair, APHL Global Health Committee and Assistant Commissioner/Director, State Laboratory Institute Massachusetts Department of Public Health 1:00 Lunch Session IV: The Global Application of Tools, Technology, and Knowledge to Counter the Consequences of Infectious Diseases: A Discussion of Priorities and Options 2:00 With the backdrop of the two days’ presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, government agencies, public health organizations, and other nongovernmental organizations. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the options and considerations for research, development, and capacity building. The complexities of interactionamong private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to the challenges and opportunities presented by an increasingly “globalized” world. Moderator: Adel Mahmoud, President, Merck Vaccines

OCR for page 175
The Impact of Globalization on Infectious Disease Emergence and Control: Exploring the Consequences and Opportunities - Workshop Summary   Invited Panel Discussants: Eduardo Gotuzzo, President, Latin American Society of Tropical Medicine and Principal Professor, University Perudad Cayetano Heredia, Peru Reinhard Kurth, President, the Robert Koch Institute, Berlin Jim LeDuc, Acting Director, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention 3:30 Roundtable Discussion 4:30 Closing Remarks / Adjournment Adel Mahmoud, President, Merck Vaccines Chair, Forum on Emerging Infections